Brief: Diasorin FY Adjusted EBITDA EUR 394 Mln
20/03/2026 16:47
March 20 (Reuters) - DiaSorin SpA DIAS.MI: PROPOSES ORDINARY DIVIDEND OF €1.30 PER SHARE, UP 8.3% VERSUS 2024 SEES 2026 REVENUE GROWTH OF 5%-6% AND EBITDA ADJUSTED MARGIN OF 32%-33% FY ADJUSTED EBITDA EUR 394 MILLION FY REVENUE EUR 1.195 BILLION GROUP FY ADJUSTED NET PROFIT EUR 223 MILLION Further company coverage: DIAS.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Diasorin
See all newsEquita upgrades Diasorin, sees 'solid' Q3
Brief: Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
European life sciences stocks rise on strong sector momentum
Italy - Factors to watch on September 21